KZIA

Kazia Therapeutics
KZIA

Overview Fund Activity

8 hedge funds and large institutions have $127K invested in Kazia Therapeutics in 2013 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.

Holders
8
Holders Change
+1
Holders Change %
+14.29%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VKH
1
Virtu KCG Holdings
New York
$62K
2
U
2
UBS
Switzerland
$17K
3
Morgan Stanley
3
Morgan Stanley
New York
$13K
4
BWFA
4
Baltimore-Washington Financial Advisors
Maryland
$5K
5
Citigroup
5
Citigroup
New York
$1K

Top Sellers

1
Bank of America
1
Bank of America
North Carolina
$28K
2
PP
2
Palladium Partners
Virginia
$0
Name Market Value Shares Shares
Change 		Shares
Change %
VKH
1
Virtu KCG Holdings
New York
$62K 14,649 +14,649 New
Bank of America
2
Bank of America
North Carolina
$28K 6,646 -2,000 -23%
U
3
UBS
Switzerland
$17K 4,039 +3,159 +359%
Morgan Stanley
4
Morgan Stanley
New York
$13K 3,007 +3,007 New
BWFA
5
Baltimore-Washington Financial Advisors
Maryland
$5K 1,110 +1,000 +909%
Creative Planning
6
Creative Planning
Kansas
$1K 200 – –
Citigroup
7
Citigroup
New York
$1K 310 +310 New
PP
8
Palladium Partners
Virginia
– – -200 Closed
TRCT
9
Tower Research Capital (TRC)
New York
– – -1 Closed
Ameriprise
10
Ameriprise
Minnesota
$0 31 +11 +55%